problems clearing cache file /var/www/joomla-uskvbl.cz/www/cache/refTableSQL/87e5d1978058f547773643d047ac41cfproblems clearing cache file /var/www/joomla-uskvbl.cz/www/cache/refTableSQL/85f9e0f38a08d2fdfc1f9970e0d09f39problems clearing cache file /var/www/joomla-uskvbl.cz/www/cache/refTableSQL/e00ef76e6db88874bca6fc769506d2edproblems clearing cache file /var/www/joomla-uskvbl.cz/www/cache/refTableSQL/4177dee0b58592f6f6eb1791eda3b1e7problems clearing cache file /var/www/joomla-uskvbl.cz/www/cache/refTableSQL/8b2e883e845bd8cd8e47cc8ed7687c89 Other stakeholders
logo
Čeština (Česká republika)English (United Kingdom)

Login



Other stakeholders PDF Print E-mail
Written by Administrator   

This chapter summarises obligations to report adverse reactions to ÚSKVBL by VMP manufacturers, wholesalers/distributors, retail sellers, sponzors of clinical trials and pharmaceutical companies responsible for post-authorisation surveillance of VMP safety.

Last Updated on Monday, 14 May 2018 12:35